Lodwig Volker, Kulzer Bernhard, Schnell Oliver, Heinemann Lutz
Roche Diagnostics, Mannheim, Germany.
Diabetesklinik Bad Mergentheim, Bad Mergentheim, Germany.
J Diabetes Sci Technol. 2014 Mar;8(2):390-396. doi: 10.1177/1932296814525826. Epub 2014 Mar 13.
The market introduction of systems for continuous glucose monitoring (CGM) some 15 years ago did not immediately revolutionize the treatment of diabetes; however, for a given group of patients, it would almost be inconceivable nowadays to imagine life without CGM. One day the development of insulin pumps together with CGM could culminate in an artificial pancreas system. The performance of the glucose sensors used for glucose measurement in the interstitial fluid in the subcutaneous tissue and the algorithms employed to analyze these data have improved so much over the past decade that current CGM systems by far outperform those of the first generations. This commentary discusses a number of aspects about what we have learned since CGM systems entered the market and what current trends exist in their usage. Some of these are major hurdles facing a more widespread usage of CGM.
大约15年前，连续血糖监测（CGM）系统进入市场时，并没有立即给糖尿病治疗带来变革；然而，对于特定的一群患者来说，如今很难想象没有CGM的生活会是什么样。总有一天，胰岛素泵与CGM的发展可能会促成人工胰腺系统的出现。在过去十年里，用于测量皮下组织间质液中葡萄糖的葡萄糖传感器的性能以及用于分析这些数据的算法都有了很大改进，以至于目前的CGM系统远比第一代系统性能优越。本评论讨论了自CGM系统进入市场以来我们所学到的一些方面，以及其当前的使用趋势。其中一些是CGM更广泛使用面临的主要障碍。
